mudpie

Company profile · 3 min read

Molagri: species-specific biopesticides

Molagri engineers modular insect virus-like particles intended to target crop pests precisely while reducing harm to pollinators and beneficial insects.

Published · Updated

What it does

Molagri is developing species-specific biopesticides designed to control pests while sparing pollinators and beneficial insects. Its approach uses engineered insect virus-like particles: a targeting element recognizes a pest-specific receptor and a payload delivers a toxin. The current homepage describes a modular platform intended for scalable fermentation and adaptation as pests evolve resistance.

The fit is a grower, crop producer or agricultural partner dealing with resistant pests, banned actives or the environmental tradeoffs of broad-spectrum crop protection. Molagri is an early biological platform, not a ready-to-buy pesticide in the sources checked. Its value depends on efficacy, field performance, manufacturing, regulatory approval and safety evidence.

Why I’d look closer

The technical thesis is specific: change the targeting element to change the pest and change the payload to change the kill mechanism. The company says it solved a cryo-EM structure of a honey-bee receptor to inform pollinator-safe design. That is a company-reported scientific milestone, not proof of field safety. The YC launch also says Molagri has produced its first viruses for testing and signed a first grower LOI; those are early development signals, not product availability.

The founder context supports the biology. The YC profile describes Zaky Hassan and Min Jin as University of Toronto PhD candidates and viral structural biologists who have published in Nature Communications and Nature Microbiology. The company’s public material emphasizes that its platform is meant to be manufactured and deployed at agricultural scale, which makes process development as important as molecular design.

What I’d ask

Which pest/crop combination is first, what are the greenhouse and field controls, and how are non-target effects measured? I’d ask for the regulatory path, environmental fate, resistance-monitoring plan, formulation, production yield and evidence behind the pollinator-safety claim. A grower LOI is a useful signal, but not a substitute for trial data.

My editorial take

Molagri is a serious deep-tech agriculture profile with a clear biological wedge. It is interesting because resistance and environmental impact are the same product problem, not two separate marketing themes. The next evidence should be field-relevant efficacy and safety, not another platform diagram.

Quick facts

Field Sourced detail
Buyer fit Growers, producers and agricultural crop-protection partners
Product thesis Modular, species-specific biopesticides using engineered VLPs
Early signal First grower LOI and first viruses for testing; company-reported
Public pricing Not exposed in the sources checked

Sources checked

Checked 2026-09-19.

Source Used for
YC company profile Product, founders and early development claims
Molagri homepage Current technology and scale/manufacturing positioning

Cohort context

Molagri is listed in Summer 2026. In our 2026-09-18 directory snapshot, 56 of 232 listed companies in that cohort have YC’s primary industry label Industrials (24.1%). This is a current-directory comparison, not an original intake count or a performance ranking. Nine-cohort dataset.

Public website snapshot

Observed 2026-09-19T16:19:00.696Z in raw homepage HTML. This records visible metadata and advertised links, not agent execution or product quality.

Signal Homepage observation
Product description metadata Observed
Canonical link Not observed in this response
H1 or H2 heading Observed
Typed structured data Not observed in this response
Docs/developer link Not observed in this response
Pricing link Not observed in this response
llms.txt link Not observed in this response
Markdown alternate Not observed in this response

Public observations · Collection method. Missing links here do not establish that a capability or file is absent elsewhere.

About the author

I cofound Lazyweb and publish Mudpie. This is an owner-written publication, not an independent testing organization. Research notes distinguish observations, sourced reporting and editorial judgment.

First1000 ↗ · X ↗